CompuGroup Medical SE & Co. KGaA (HAM:COP)

HAM:COP Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,201	1,186	1,228	1,175	1,063	869.13
Other Revenue	0.6	0.6	0.11	0.25	0.08	0.08
Revenue	1,201	1,186	1,228	1,175	1,063	869.21
Revenue Growth (YoY)	0.70%	-3.39%	4.52%	10.55%	22.26%	12.82%
Cost of Revenue	798.78	784.28	813.16	763.1	689.15	533.23
Gross Profit	402.42	402.03	414.75	411.71	373.55	335.98
Selling, General & Admin	12.01	12.01	11.85	11.63	10.78	8.82
Other Operating Expenses	192.91	172.24	164.46	179.32	144.21	126.97
Operating Expenses	325.89	304.11	292.09	313.14	266.92	215.79
Operating Income	76.53	97.92	122.66	98.56	106.63	120.19
Interest Expense	-30.88	-31.43	-24.32	-9.12	-5.4	-5.3
Interest & Investment Income	1.51	1.32	1.06	0.81	0.72	1.52
Earnings From Equity Investments	0.8	-0.8	0.62	-0.1	0.03	-0.93
Currency Exchange Gain (Loss)	-3.13	0.02	-2.94	1.08	-0.39	-4.27
Other Non Operating Income (Expenses)	-12.51	-10.18	-15.18	17.27	0.74	-0.92
EBT Excluding Unusual Items	32.32	56.85	81.9	108.51	102.34	110.29
Gain (Loss) on Sale of Assets	5.85	5.85	1.04	0.16	1.69	0.14
Asset Writedown	-1.87	-1.87	-11.45	-0.34	-6.15	-
Other Unusual Items	-1.54	-3.53	0.64	-1.51	0	-
Pretax Income	39.35	61.89	72.67	106.82	97.87	110.43
Income Tax Expense	20.44	27.13	25.8	32.7	28.84	37.01
Earnings From Continuing Operations	18.91	34.76	46.87	74.12	69.03	73.42
Net Income to Company	18.91	34.76	46.87	74.12	69.03	73.42
Minority Interest in Earnings	-0.66	-0.16	-0.96	-0.71	-0.06	-0.23
Net Income	18.25	34.6	45.92	73.41	68.97	73.19
Net Income to Common	18.25	34.6	45.92	73.41	68.97	73.19
Net Income Growth	-43.84%	-24.64%	-37.45%	6.44%	-5.77%	11.20%
Shares Outstanding (Basic)	52	52	52	52	53	51
Shares Outstanding (Diluted)	53	53	52	52	53	52
Shares Change (YoY)	1.10%	0.63%	0.32%	-1.29%	1.15%	5.96%
EPS (Basic)	0.35	0.67	0.88	1.41	1.30	1.43
EPS (Diluted)	0.35	0.66	0.88	1.40	1.30	1.40
EPS Growth	-42.89%	-24.92%	-37.21%	7.69%	-7.14%	5.26%
Free Cash Flow	142.8	104.08	160.56	119.18	138.23	132.25
Free Cash Flow Per Share	2.70	1.97	3.06	2.28	2.61	2.52
Dividend Per Share	0.050	0.050	1.000	0.500	0.500	0.500
Dividend Growth	-95.00%	-95.00%	100.00%	-	-	-
Gross Margin	33.50%	33.89%	33.78%	35.05%	35.15%	38.65%
Operating Margin	6.37%	8.25%	9.99%	8.39%	10.03%	13.83%
Profit Margin	1.52%	2.92%	3.74%	6.25%	6.49%	8.42%
Free Cash Flow Margin	11.89%	8.77%	13.08%	10.14%	13.01%	15.21%
EBITDA	124.51	146.86	169.81	151.77	160.91	158.65
EBITDA Margin	10.37%	12.38%	13.83%	12.92%	15.14%	18.25%
D&A For EBITDA	47.98	48.94	47.15	53.2	54.28	38.46
EBIT	76.53	97.92	122.66	98.56	106.63	120.19
EBIT Margin	6.37%	8.25%	9.99%	8.39%	10.03%	13.83%
Effective Tax Rate	51.95%	43.84%	35.50%	30.61%	29.47%	33.51%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.